z-logo
open-access-imgOpen Access
Effects of Ubiquinol-10 on MicroRNA-146a Expression In Vitro and In Vivo
Author(s) -
Constance Schmelzer,
Mitsuaki Kitano,
Gerald Rimbach,
Petra Niklowitz,
Thomas Menke,
Kazunori Hosoe,
Frank Döring
Publication year - 2009
Publication title -
mediators of inflammation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.37
H-Index - 97
eISSN - 1466-1861
pISSN - 0962-9351
DOI - 10.1155/2009/415437
Subject(s) - ubiquinol , in vivo , in vitro , microrna , reactive oxygen species , luciferase , lipopolysaccharide , gene expression , chemistry , microbiology and biotechnology , biology , biochemistry , gene , immunology , transfection , apoptosis , coenzyme q – cytochrome c reductase , genetics , cytochrome c
MicroRNAs (miRs) are involved in key biological processes via suppression of gene expression at posttranscriptional levels. According to their superior functions, subtle modulation of miR expression by certain compounds or nutrients is desirable under particular conditions. Bacterial lipopolysaccharide (LPS) induces a reactive oxygen species-/NF-κB-dependent pathway which increases the expression of the anti-inflammatory miR-146a. We hypothesized that this induction could be modulated by the antioxidant ubiquinol-10. Preincubation of human monocytic THP-1 cells with ubiquinol-10 reduced the LPS-induced expression level of miR-146a to 78.9 ± 13.22%. In liver samples of mice injected with LPS, supplementation with ubiquinol-10 leads to a reduction of LPS-induced miR-146a expression to 78.12 ± 21.25%. From these consistent in vitro and in vivo data, we conclude that ubiquinol-10 may fine-tune the inflammatory response via moderate reduction of miR-146a expression.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom